ALGBE Global Bioenergies SA

Jean-Claude Lumaret, former CEO of Carbios, joins the Board of Directors of Global Bioenergies

Jean-Claude Lumaret, former CEO of Carbios, joins the Board of Directors of Global Bioenergies

PRESS RELEASE

Jean-Claude Lumaret, former CEO of Carbios,

joins the Board of Directors of Global Bioenergies

Evry, 18 January 2024 – 05:45 p.m.: Global Bioenergies (FR0011052257 – ALGBE), a player in industrial biotechnology, announces the co-option of Jean-Claude Lumaret, former Chief Executive Officer of Carbios, as an independent director. He replaces Alain Fanet, who resigned today to pursue other professional interests.

Jean-Claude Lumaret, co-founder and CEO of Carbios for almost 10 years, has led the development and launched the industrialisation of breakthrough technologies that are definitely environmental, aimed at reinventing the life cycle of plastics and textiles.

Jean-Claude Lumaret said: "The project led by Global Bioenergies has many similarities with that of Carbios: an innovative biological process offering a new solution to protect the environment. I now want to use my experience to help Global Bioenergies' scale-up and enable the Company to disseminate this new decarbonation solution as widely as possible.

Corinne Granger, Chairwoman of the Board of Directors, added: "We would like to thank Alain Fanet for his contribution to the Board of Directors over the last four years, and welcome Jean-Claude Lumaret. His vast experience and keen understanding of the risks and challenges facing an innovative company like Global Bioenergies will enable him to participate effectively in the Company's strategic decisions."

The Board of Directors of Global Bioenergies is currently composed of 7 members: six directors and one observer; three women and four men.

About GLOBAL BIOENERGIES

Global Bioenergies substitutes products of fossil origin with products of natural origin. In their quest for naturalness without compromising on performance, the cosmetics players are the Company's first customers. By 2027, the Company will be operating its innovative process in a large-scale plant. By 2030, the Company plans to become a leader in the huge emerging market for sustainable aviation fuels, in order to fight against global warming. Global Bioenergies is listed on Euronext Growth in Paris (FR0011052257 - ALGBE). L'Oréal is its largest shareholder, with a 13.5% stake.

Contacts

 



GLOBAL BIOENERGIES

+33 (0)1 64 98 20 50





 



Follow our news



 



Receive information about Global Bioenergies directly by subscribing to our news feed on



 



Follow us on LinkedIn





 
  



 



NewCap – Investor relations



Louis-Victor Delouvrier

Aurélie Manavarere





+33 (0)1 44 71 94 94



 



NewCap – Media relations



 



Nicolas Merigeau



+33 (0)1 44 71 94 98

Attachment



EN
18/01/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Global Bioenergies SA

 PRESS RELEASE

Global Bioenergies publie son Document d’enregistrement universel 2023

Global Bioenergies publie son Document d’enregistrement universel 2023 COMMUNIQUE DE PRESSE Global Bioenergies publie son Document d’enregistrement universel 2023 Evry, le 23 avril 2024 – 18h30 : Global Bioenergies (FR0011052257 – ALGBE), acteur de la biologie industrielle, annonce aujourd’hui la publication de son Document d’enregistrement universel 2023, rendu disponible sur le site internet de la Société dans la rubrique « Investisseurs ». Ce document permet de présenter en détail la stratégie de la Société, des cosmétiques aux carburants d'aviation durables à partir d'une seule et mêm...

 PRESS RELEASE

Global Bioenergies certifiée ISO 9001

Global Bioenergies certifiée ISO 9001 COMMUNIQUE DE PRESSE Global Bioenergies certifiée ISO 9001 Evry, le 16 avril 2024 – 17h45 : Global Bioenergies (FR0011052257 – ALGBE), acteur de la biologie industrielle, annonce l’obtention de la certification ISO 9001:2015, reconnue à l’échelle mondiale en tant que référence en matière de qualité. Cette certification vient formaliser 3 ans d’efforts de la Société dans la mise en place de ses activités de production et de commercialisation. Ses objectifs principaux consistent à assurer la qualité des produits commercialisés et la satisfaction clients...

 PRESS RELEASE

Global Bioenergies has received letters of intent for its plant projec...

Global Bioenergies has received letters of intent for its plant project corresponding to forecasted annual sales of over €70 million PRESS RELEASE Global Bioenergies has received letters of intent for itsplant project corresponding to forecasted annual salesof over €70 million The plant will focus on high added-value cosmetics markets, with annual production capacity rescaled to 2,500 tons The total volume of letters of intent exceeds the plant's production capacityThe plant will also enable to initiate the sustainable aviation fuels market CAPEX and plant design specifications clarifi...

 PRESS RELEASE

Global Bioenergies a reçu des lettres d’intention pour son projet d’us...

Global Bioenergies a reçu des lettres d’intention pour son projet d’usine correspondant à un chiffre d’affaires annuel projeté de plus de 70 millions d’euros COMMUNIQUE DE PRESSE Global Bioenergies a reçu des lettres d’intention pour son projet d’usine correspondant à un chiffre d’affaires annuel projeté de plus de 70 millions d’euros L’usine se focalisera sur les marchés cosmétiques à haute valeur ajoutée avec une capacité de production annuelle redimensionnée à 2 500 tonnes Le volume total des lettres d’intention dépasse la capacité de production de l’usineL’usine permettra également...

 PRESS RELEASE

Global Bioenergies: strong reduction of the loss in 2023 thanks to a s...

Global Bioenergies: strong reduction of the loss in 2023 thanks to a significant increase in commercial activity PRESS RELEASE Global Bioenergies: strong reduction of the loss in 2023 thanks to a significant increase in commercial activity Sales exceeding €3M for the first timeConsolidated net loss significantly improved to -€8.7M compared to -€12M in 2022Gross cash position of €11.7M at 31 December 2023 compared to €8.8M the previous yearSuccessful commercialization of the first tons of Isonaturane™ 12 to several customers including L'OréalASTM certification received for the production o...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch